Whitnell & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$145K Hold
1,100
0.04% 162
2019
Q3
$123K Hold
1,100
0.04% 167
2019
Q2
$122K Buy
1,100
+200
+22% +$23.6K 0.05% 158
2019
Q1
$117K Sell
900
-100
-10% -$12.2K 0.05% 159
2018
Q4
$116K Hold
1,000
0.05% 157
2018
Q3
$107K Hold
1,000
0.04% 154
2018
Q2
$85K Sell
1,000
-185
-16% -$15.2K 0.04% 157
2018
Q1
$92K Buy
1,185
+185
+19% +$14.9K 0.04% 155
2017
Q4
$84K Sell
1,000
-250
-20% -$21.3K 0.04% 158
2017
Q3
$107K Hold
1,250
0.05% 146
2017
Q2
$103K Hold
1,250
0.05% 146
2017
Q1
$105K Hold
1,250
0.05% 146
2016
Q4
$92K Hold
1,250
0.04% 151
2016
Q3
$100K Sell
1,250
-250
-17% -$20K 0.03% 154
2016
Q2
$118K Hold
1,500
0.04% 155
2016
Q1
$108K Hold
1,500
0.04% 159
2015
Q4
$126K Hold
1,500
0.05% 151
2015
Q3
$126K Hold
1,500
0.05% 148
2015
Q2
$125K Hold
1,500
0.05% 149
2015
Q1
$109K Hold
1,500
0.04% 150
2014
Q4
$103K Hold
1,500
0.04% 159
2014
Q3
$97K Hold
1,500
0.04% 164
2014
Q2
$93K Hold
1,500
0.04% 165
2014
Q1
$88K Hold
1,500
0.04% 164
2013
Q4
$76K Sell
1,500
-8,000
-84% -$401K 0.03% 170
2013
Q3
$478K Hold
9,500
0.24% 102
2013
Q2
$467K Buy
+9,500
New +$517K 0.23% 97

Other funds holding LLY

Whitnell & Co's LLY Position: Q4 2019 in Review

Whitnell & Co held its Eli Lilly (LLY) position steady in Q4 2019 at 1,100 shares worth $145K. The position accounts for 0.04% of the portfolio, ranked #162.

Whitnell & Co first reported a position in LLY in Q2 2013 and has held it in 27 quarters since. The position peaked at $478K in Q3 2013. 1,672 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Whitnell & Co held 1,100 shares of Eli Lilly worth $145K as of Q4 2019.
  • Whitnell & Co left its Eli Lilly share count unchanged in Q4 2019.
  • Eli Lilly made up 0.04% of Whitnell & Co's portfolio in Q4 2019, its #162 holding.
  • Whitnell & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's Eli Lilly position peaked at $478K in Q3 2013.
  • 1,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.